Finance

Beta
Lists
VIR:NASDAQ
Vir Biotechnology Inc
$8.65
-5.46%
(-0.50) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VIR...
Open
$9.09
High
$9.19
Low
$8.63
Mkt. cap
1.46B
Avg. vol.
1.60M
Volume
0.00
52-wk high
$11.50
52-wk low
$4.16
EPS
-$3.14
Beta
1.65
Shares outstanding
168.65M
No. of employees
367
Open
$9.09
High
$9.19
Low
$8.63
Mkt. cap
1.46B
Avg. vol.
1.60M
Volume
0.00
52-wk high
$11.50
52-wk low
$4.16
EPS
-$3.14
Beta
1.65
Shares outstanding
168.65M
No. of employees
367
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to VIR in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for VIR in the last 3 months.
Highest
Current $8.65
$30.00 (+246.82%)
Average
$20.86 (+141.16%)
Lowest
$16.00 (+84.97%)
News stories
From sources across the web
About Vir Biotechnology Inc
CEOMarianne De Backer
Employees367
FoundedApr 7, 2016
HeadquartersSan Francisco, California, United States
SectorBiotechnology
Websitevir.bio
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.85 / $0.48
-276.62%miss
Revenue / Est. (USD)
-29.00K / 109.28M
-100.03%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.21M
240.00K
64.07M
-29.00K
Cost of goods sold
97.52M
151.45M
88.46M
109.81M
Cost of revenue
97.52M
151.45M
88.46M
109.81M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.28M
22.23M
23.62M
23.34M
Operating expense
22.28M
22.23M
23.62M
23.34M
Total operating expenses
119.80M
173.68M
112.07M
133.15M
Operating income
-118.59M
-173.44M
-48.00M
-133.18M
Other non operating income
226.00K
-228.00K
-335.00K
-254.00K
EBT including unusual items
-110.79M
-162.97M
-43.06M
-125.52M
EBT excluding unusual items
-107.58M
-164.31M
-40.53M
-126.24M
Income tax expense
170.00K
168.00K
-137.00K
170.00K
Effective tax rate
-0.15%
-0.10%
0.32%
-0.14%
Other operating expenses
-
-
-
-
Net income
-110.96M
-163.14M
-42.92M
-125.70M
Net profit margin
-9,139.87%
-67,975.42%
-66.99%
433,431.03%
Earnings per share
-0.80
-1.17
-0.31
-0.85
Interest and investment income
10.78M
9.36M
7.80M
7.19M
Interest expense
-
-
-
-
Net interest expenses
10.78M
9.36M
7.80M
7.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
-115.67M
-170.44M
-45.10M
-130.37M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more